Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Iovance Biotherapeutics price target raised to $53 from $44 at Chardan » 08:00
08/07/20
08/07
08:00
08/07/20
08:00
IOVA

Iovance Biotherapeutics

$31.21 /

+0.33 (+1.07%)

Chardan analyst Geulah…

Chardan analyst Geulah Livshits raised the firm's price target on Iovance Biotherapeutics to $53 from $44 and keeps a Buy rating on the shares after the company reported Q2 results and affirmed guidance for a BLA filing for lifileucel in melanoma by the end of the year. The analyst updated his model for the Q2 results and higher assumptions on pricing based in part on durability in melanoma, Livshits noted.

ShowHide Related Items >><<
IOVA Iovance Biotherapeutics
$31.21 /

+0.33 (+1.07%)

IOVA Iovance Biotherapeutics
$31.21 /

+0.33 (+1.07%)

05/29/20 Piper Sandler
Piper says Iovance data for lifileucel continue to 'mature favorably'
05/28/20 Piper Sandler
Iovance melanoma data 'fully supportive of approval,' says Piper Sandler
04/29/20 Oppenheimer
Iovance Biotherapeutics price target raised to $43 from $35 at Oppenheimer
04/29/20 H.C. Wainwright
Iovance Biotherapeutics price target raised to $48 from $36 at H.C. Wainwright
IOVA Iovance Biotherapeutics
$31.21 /

+0.33 (+1.07%)

  • 29
    May
IOVA Iovance Biotherapeutics
$31.21 /

+0.33 (+1.07%)

IOVA Iovance Biotherapeutics
$31.21 /

+0.33 (+1.07%)

IOVA Iovance Biotherapeutics
$31.21 /

+0.33 (+1.07%)

Thursday
Hot Stocks
Avid Bioservices selected by Iovance to lead process development » 08:30
08/06/20
08/06
08:30
08/06/20
08:30
CDMO

Avid Bioservices

$7.57 /

+0.065 (+0.87%)

, IOVA

Iovance Biotherapeutics

$30.88 /

+0.105 (+0.34%)

Avid Bioservices, Inc.…

Avid Bioservices, Inc. (CDMO) announced that Iovance Biotherapeutics (IOVA) has selected Avid to provide process development, pilot-batch manufacturing and CGMP manufacturing services to support development of IOV-3001, a novel antibody cytokine engrafted protein.Cell line development activities for IOV-3001 are currently being conducted by Aragen Bioscience under a subcontracting agreement with Avid. In parallel with cell line development, Avid will commence analytical activities, upstream and downstream process development, and pilot-scale non-GMP manufacturing for IOV-3001. Following completion of these activities, Avid will advance to CGMP manufacturing of IOV-3001 within Avid's state-of-the-art Myford facility in Tustin, CA.

ShowHide Related Items >><<
IOVA Iovance Biotherapeutics
$30.88 /

+0.105 (+0.34%)

CDMO Avid Bioservices
$7.57 /

+0.065 (+0.87%)

CDMO Avid Bioservices
$7.57 /

+0.065 (+0.87%)

12/10/19 First Analysis
Avid Bioservices upgraded to Strong Buy from Outperform at First Analysis
10/16/19 Stephens
Avid Bioservices initiated with an Overweight at Stephens
10/16/19
Craig-Hallum bullish on Avid Bioservices, initiates with a Buy
10/16/19 Craig-Hallum
Avid Bioservices initiated with a Buy at Craig-Hallum
IOVA Iovance Biotherapeutics
$30.88 /

+0.105 (+0.34%)

05/29/20 Piper Sandler
Piper says Iovance data for lifileucel continue to 'mature favorably'
05/28/20 Piper Sandler
Iovance melanoma data 'fully supportive of approval,' says Piper Sandler
04/29/20 Oppenheimer
Iovance Biotherapeutics price target raised to $43 from $35 at Oppenheimer
04/29/20 H.C. Wainwright
Iovance Biotherapeutics price target raised to $48 from $36 at H.C. Wainwright
IOVA Iovance Biotherapeutics
$30.88 /

+0.105 (+0.34%)

CDMO Avid Bioservices
$7.57 /

+0.065 (+0.87%)

  • 29
    May
IOVA Iovance Biotherapeutics
$30.88 /

+0.105 (+0.34%)

IOVA Iovance Biotherapeutics
$30.88 /

+0.105 (+0.34%)

CDMO Avid Bioservices
$7.57 /

+0.065 (+0.87%)

IOVA Iovance Biotherapeutics
$30.88 /

+0.105 (+0.34%)

CDMO Avid Bioservices
$7.57 /

+0.065 (+0.87%)

Over a month ago
Hot Stocks
Iovance Biotherapeutics disclosed resignation of CFO Timothy Morris » 07:43
06/15/20
06/15
07:43
06/15/20
07:43
IOVA

Iovance Biotherapeutics

$29.55 /

-0.05 (-0.17%)

Iovance Biotherapeutics…

Iovance Biotherapeutics disclosed late Friday Timothy Morris no longer serves as the company's Chief Financial Officer, effective as of June 10. Effective as of June 10, Michael Swartzburg, the company's Vice President, Finance, was appointed to replace Morris as the interim Principal Financial Officer and Principal Accounting Officer. Swartzburg has served as the company's Vice President, Finance since March 2018. Previously, Mr. Swartzburg provided contracted financial and board of director advisory services to various public and private biotechnology and technology companies from August 2016 through March 2018.

ShowHide Related Items >><<
IOVA Iovance Biotherapeutics
$29.55 /

-0.05 (-0.17%)

IOVA Iovance Biotherapeutics
$29.55 /

-0.05 (-0.17%)

05/29/20 Piper Sandler
Piper says Iovance data for lifileucel continue to 'mature favorably'
05/28/20 Piper Sandler
Iovance melanoma data 'fully supportive of approval,' says Piper Sandler
04/29/20 Oppenheimer
Iovance Biotherapeutics price target raised to $43 from $35 at Oppenheimer
04/29/20 H.C. Wainwright
Iovance Biotherapeutics price target raised to $48 from $36 at H.C. Wainwright
IOVA Iovance Biotherapeutics
$29.55 /

-0.05 (-0.17%)

IOVA Iovance Biotherapeutics
$29.55 /

-0.05 (-0.17%)

IOVA Iovance Biotherapeutics
$29.55 /

-0.05 (-0.17%)

IOVA Iovance Biotherapeutics
$29.55 /

-0.05 (-0.17%)

Recommendations
Piper says Iovance data for lifileucel continue to 'mature favorably' » 13:17
05/29/20
05/29
13:17
05/29/20
13:17
IOVA

Iovance Biotherapeutics

$31.56 /

-1.105 (-3.38%)

Piper Sandler analyst…

Piper Sandler analyst Joseph Catanzaro said data from cohort 2 of lifileucel's melanoma study are continuing to "mature favorably" and he sees "no real surprises with this update." The analyst, who still thinks the durability of responses will make lifileucel "a very meaningful option" for post-PD-1 melanoma patients, believes that lifileucel's data package is fully supportive of approval in this setting. Catanzaro keeps an Overweight rating on Iovance Biotherapeutics shares.

ShowHide Related Items >><<
IOVA Iovance Biotherapeutics
$31.56 /

-1.105 (-3.38%)

IOVA Iovance Biotherapeutics
$31.56 /

-1.105 (-3.38%)

05/28/20 Piper Sandler
Iovance melanoma data 'fully supportive of approval,' says Piper Sandler
04/29/20 Oppenheimer
Iovance Biotherapeutics price target raised to $43 from $35 at Oppenheimer
04/29/20 H.C. Wainwright
Iovance Biotherapeutics price target raised to $48 from $36 at H.C. Wainwright
04/27/20 Piper Sandler
AACR abstract for Moffitt study positive for Iovance, says Piper Sandler
IOVA Iovance Biotherapeutics
$31.56 /

-1.105 (-3.38%)

  • 29
    May
IOVA Iovance Biotherapeutics
$31.56 /

-1.105 (-3.38%)

IOVA Iovance Biotherapeutics
$31.56 /

-1.105 (-3.38%)

IOVA Iovance Biotherapeutics
$31.56 /

-1.105 (-3.38%)

Hot Stocks
Iovance presents data for TIL therapy lifileucel in advanced melanoma at ASCO » 08:41
05/29/20
05/29
08:41
05/29/20
08:41
IOVA

Iovance Biotherapeutics

$32.67 /

-5.455 (-14.31%)

Iovance Biotherapeutics…

Iovance Biotherapeutics presented long-term interim data from Cohort 2 in the C-144-01 study of lifileucel in advanced melanoma during an oral session at the American Society of Clinical Oncology's ASCO20 Virtual Scientific Program. "We are very pleased to present the long term follow up data for lifileucel in melanoma at the ASCO Scientific Program," said Maria Fardis, Ph.D., President and Chief Executive Officer of Iovance Biotherapeutics. "The median duration of response has not been reached at 18.7 months of study follow up supporting potential benefit of the one-time treatment of lifileucel TIL therapy in advanced melanoma patients. The latest data at ASCO also demonstrate durable responses with lifileucel across the broad spectrum of our study population, including a wide age range of metastatic melanoma patients who have received prior anti-CTLA-4 and BRAF targeted treatments, and equally in patients with PD-L1 high and low status." Jason Chesney, MD PhD, Director, James Graham Brown Cancer Center, University of Louisville and C-144-01 study investigator stated, "One of the greatest challenges oncologists face today is the treatment of melanoma patients who have progressed on immune checkpoint and BRAF/MEK inhibitors. The preliminary results of the C-144-01 study demonstrate that autologous tumor infiltrating lymphocytes (TILs; lifileucel) induce durable clinical responses in a significant percentage of this moribund population. Importantly, this new study opens the door for trials of TILs in many other cancer types and in combination with our growing repertoire of immunomodulatory agents."

ShowHide Related Items >><<
IOVA Iovance Biotherapeutics
$32.67 /

-5.455 (-14.31%)

IOVA Iovance Biotherapeutics
$32.67 /

-5.455 (-14.31%)

05/28/20 Piper Sandler
Iovance melanoma data 'fully supportive of approval,' says Piper Sandler
04/29/20 Oppenheimer
Iovance Biotherapeutics price target raised to $43 from $35 at Oppenheimer
04/29/20 H.C. Wainwright
Iovance Biotherapeutics price target raised to $48 from $36 at H.C. Wainwright
04/27/20 Piper Sandler
AACR abstract for Moffitt study positive for Iovance, says Piper Sandler
IOVA Iovance Biotherapeutics
$32.67 /

-5.455 (-14.31%)

  • 29
    May
IOVA Iovance Biotherapeutics
$32.67 /

-5.455 (-14.31%)

IOVA Iovance Biotherapeutics
$32.67 /

-5.455 (-14.31%)

IOVA Iovance Biotherapeutics
$32.67 /

-5.455 (-14.31%)

Syndicate
Iovance Biotherapeutics 16.9M share Secondary priced at $31.00 » 23:25
05/28/20
05/28
23:25
05/28/20
23:25
IOVA

Iovance Biotherapeutics

$32.67 /

-5.455 (-14.31%)

The deal size was…

The deal size was increased to $525M in common stock from $500M in common stock. Jefferies and Goldman Sachs acted as joint book running managers for the offering.

ShowHide Related Items >><<
IOVA Iovance Biotherapeutics
$32.67 /

-5.455 (-14.31%)

IOVA Iovance Biotherapeutics
$32.67 /

-5.455 (-14.31%)

05/28/20 Piper Sandler
Iovance melanoma data 'fully supportive of approval,' says Piper Sandler
04/29/20 Oppenheimer
Iovance Biotherapeutics price target raised to $43 from $35 at Oppenheimer
04/29/20 H.C. Wainwright
Iovance Biotherapeutics price target raised to $48 from $36 at H.C. Wainwright
04/27/20 Piper Sandler
AACR abstract for Moffitt study positive for Iovance, says Piper Sandler
IOVA Iovance Biotherapeutics
$32.67 /

-5.455 (-14.31%)

  • 29
    May
IOVA Iovance Biotherapeutics
$32.67 /

-5.455 (-14.31%)

IOVA Iovance Biotherapeutics
$32.67 /

-5.455 (-14.31%)

IOVA Iovance Biotherapeutics
$32.67 /

-5.455 (-14.31%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 13:07
05/28/20
05/28
13:07
05/28/20
13:07
TWTR

Twitter

$32.18 /

-0.88 (-2.66%)

, FB

Facebook

$230.27 /

+1.1 (+0.48%)

, HPQ

HP Inc.

$15.17 /

-1.96 (-11.44%)

, BA

Boeing

$154.10 /

+4.64 (+3.10%)

, HTZ

Hertz

$1.12 /

-0.19 (-14.50%)

, DHC

Diversified Healthcare Trust

$3.75 /

+0.515 (+15.94%)

, TGI

Triumph Group

$11.10 /

+2.92 (+35.70%)

, DLTR

Dollar Tree

$97.48 /

+10.05 (+11.49%)

, IOVA

Iovance Biotherapeutics

$32.41 /

-5.71 (-14.98%)

, PLT

Plantronics

$13.09 /

-1.57 (-10.71%)

Stock futures were mixed…

Open Full Text

ShowHide Related Items >><<
TWTR Twitter
$32.18 /

-0.88 (-2.66%)

TGI Triumph Group
$11.10 /

+2.92 (+35.70%)

PLT Plantronics
$13.09 /

-1.57 (-10.71%)

IOVA Iovance Biotherapeutics
$32.41 /

-5.71 (-14.98%)

HTZ Hertz
$1.12 /

-0.19 (-14.50%)

HPQ HP Inc.
$15.17 /

-1.96 (-11.44%)

FB Facebook
$230.27 /

+1.1 (+0.48%)

DLTR Dollar Tree
$97.48 /

+10.05 (+11.49%)

DHC Diversified Healthcare Trust
$3.75 /

+0.515 (+15.94%)

BA Boeing
$154.10 /

+4.64 (+3.10%)

TWTR Twitter
$32.18 /

-0.88 (-2.66%)

05/27/20 Cowen
Cowen says Twitter 'will be fine,' but Republicans could support Facebook suit
05/06/20 China Renaissance
Twitter price target lowered to $23 from $25 at China Renaissance
05/01/20
Fly Intel: Top five analyst downgrades
05/01/20 Deutsche Bank
Twitter price target raised to $28 from $22 at Deutsche Bank
FB Facebook
$230.27 /

+1.1 (+0.48%)

05/27/20 Citi
Facebook price target raised to $275 from $245 at Citi
05/21/20 Stifel
Facebook price target raised to $260 from $245 at Stifel
05/20/20 Deutsche Bank
Facebook Shops could be $30B revenue opportunity, says Deutsche Bank
HPQ HP Inc.
$15.17 /

-1.96 (-11.44%)

05/28/20
Fly Intel: Top five analyst downgrades
05/28/20 JPMorgan
HP Inc. downgraded to Neutral from Overweight at JPMorgan
05/26/20 Credit Suisse
HP Inc. price target lowered to $17 from $22 at Credit Suisse
05/22/20 JPMorgan
HP shares worth owning through downturn, says JPMorgan
BA Boeing
$154.10 /

+4.64 (+3.10%)

05/28/20 BMO Capital
Hexcel price target raised to $45 from $37 at BMO Capital
05/22/20 Canaccord
Boeing price target lowered to $155 from $175 at Canaccord
05/20/20 RBC Capital
RBC starts Boeing at Outperform on favorable risk/reward profile
05/20/20 RBC Capital
Boeing initiated with an Outperform at RBC Capital
HTZ Hertz
$1.12 /

-0.19 (-14.50%)

05/05/20 Morgan Stanley
2020 may not be quite as bad as feared for used cars, says Morgan Stanley
04/27/20
Fly Intel: Top five analyst downgrades
04/27/20 Barclays
Barclays downgrades Hertz to Underweight on risk of capital call
04/27/20 Barclays
Hertz downgraded to Underweight from Equal Weight at Barclays
DHC Diversified Healthcare Trust
$3.75 /

+0.515 (+15.94%)

05/19/20 RBC Capital
Diversified Healthcare Trust price target lowered to $3 from $7 at RBC Capital
03/11/20 Mizuho
Sabra Health Care to be pressured by coronavirus at facility, says Mizuho
01/16/20 Wells Fargo
Diversified Healthcare Trust cut to Equal Weight from Overweight at Wells Fargo
01/07/20 Raymond James
Healthcare REIT sector downgraded to Market Weight at Raymond James
TGI Triumph Group
$11.10 /

+2.92 (+35.70%)

03/20/20 BofA
BofA double downgrades Triumph, slashes price target amid COVID-19 impact
03/20/20 BofA
Triumph Group downgraded to Underperform from Buy at BofA
03/11/20 Goldman Sachs
Goldman cuts targets across Aerospace coverage for COVID-19 impact
08/23/19
Fly Intel: Top five analyst downgrades
DLTR Dollar Tree
$97.48 /

+10.05 (+11.49%)

05/28/20 Wells Fargo
Dollar Tree price target raised to $125 from $97 at Wells Fargo
05/26/20 Deutsche Bank
Dollar Tree price target raised to $97 from $87 at Deutsche Bank
05/18/20 Gordon Haskett
Colgate, Dollar Tree speculated as possible Peltz targets by Gordon Haskett
05/18/20
Fly Intel: Top five analyst initiations
IOVA Iovance Biotherapeutics
$32.41 /

-5.71 (-14.98%)

05/28/20 Piper Sandler
Iovance melanoma data 'fully supportive of approval,' says Piper Sandler
04/29/20 Oppenheimer
Iovance Biotherapeutics price target raised to $43 from $35 at Oppenheimer
04/29/20 H.C. Wainwright
Iovance Biotherapeutics price target raised to $48 from $36 at H.C. Wainwright
04/27/20 Piper Sandler
AACR abstract for Moffitt study positive for Iovance, says Piper Sandler
PLT Plantronics
$13.09 /

-1.57 (-10.71%)

05/28/20 Cowen
Plantronics price target lowered to $19 from $24 at Cowen
04/16/20 Morgan Stanley
Morgan Stanley cuts Plantronics to Underweight citing upcoming challenges
04/16/20 Morgan Stanley
Plantronics downgraded to Underweight from Equal Weight at Morgan Stanley
03/30/20 JPMorgan
Plantronics downgraded to Underweight from Neutral at JPMorgan
TWTR Twitter
$32.18 /

-0.88 (-2.66%)

TGI Triumph Group
$11.10 /

+2.92 (+35.70%)

PLT Plantronics
$13.09 /

-1.57 (-10.71%)

IOVA Iovance Biotherapeutics
$32.41 /

-5.71 (-14.98%)

HTZ Hertz
$1.12 /

-0.19 (-14.50%)

HPQ HP Inc.
$15.17 /

-1.96 (-11.44%)

FB Facebook
$230.27 /

+1.1 (+0.48%)

DLTR Dollar Tree
$97.48 /

+10.05 (+11.49%)

DHC Diversified Healthcare Trust
$3.75 /

+0.515 (+15.94%)

BA Boeing
$154.10 /

+4.64 (+3.10%)

  • 29
    May
TWTR Twitter
$32.18 /

-0.88 (-2.66%)

PLT Plantronics
$13.09 /

-1.57 (-10.71%)

IOVA Iovance Biotherapeutics
$32.41 /

-5.71 (-14.98%)

HTZ Hertz
$1.12 /

-0.19 (-14.50%)

HPQ HP Inc.
$15.17 /

-1.96 (-11.44%)

FB Facebook
$230.27 /

+1.1 (+0.48%)

DLTR Dollar Tree
$97.48 /

+10.05 (+11.49%)

BA Boeing
$154.10 /

+4.64 (+3.10%)

TWTR Twitter
$32.18 /

-0.88 (-2.66%)

PLT Plantronics
$13.09 /

-1.57 (-10.71%)

IOVA Iovance Biotherapeutics
$32.41 /

-5.71 (-14.98%)

HTZ Hertz
$1.12 /

-0.19 (-14.50%)

HPQ HP Inc.
$15.17 /

-1.96 (-11.44%)

FB Facebook
$230.27 /

+1.1 (+0.48%)

DLTR Dollar Tree
$97.48 /

+10.05 (+11.49%)

TWTR Twitter
$32.18 /

-0.88 (-2.66%)

PLT Plantronics
$13.09 /

-1.57 (-10.71%)

IOVA Iovance Biotherapeutics
$32.41 /

-5.71 (-14.98%)

HTZ Hertz
$1.12 /

-0.19 (-14.50%)

HPQ HP Inc.
$15.17 /

-1.96 (-11.44%)

FB Facebook
$230.27 /

+1.1 (+0.48%)

DLTR Dollar Tree
$97.48 /

+10.05 (+11.49%)

DHC Diversified Healthcare Trust
$3.75 /

+0.515 (+15.94%)

BA Boeing
$154.10 /

+4.64 (+3.10%)

On The Fly
Fly Intel: Pre-market Movers » 09:12
05/28/20
05/28
09:12
05/28/20
09:12
ALXN

Alexion

$106.17 /

+3.4 (+3.31%)

, AMGN

Amgen

$224.81 /

+2.55 (+1.15%)

, BA

Boeing

$149.46 /

+4.77 (+3.30%)

, DLTR

Dollar Tree

$87.43 /

+2.26 (+2.65%)

, LL

Lumber Liquidators

$9.53 /

+0.79 (+9.04%)

, TGI

Triumph Group

$8.18 /

+1.92 (+30.67%)

, CSIQ

Canadian Solar

$19.29 /

+0.265 (+1.39%)

, WDAY

Workday

$170.10 /

+1.72 (+1.02%)

, DG

Dollar General

$186.80 /

+6.41 (+3.55%)

, BURL

Burlington Stores

$210.31 /

+1.44 (+0.69%)

, ANF

Abercrombie & Fitch

$13.08 /

+0.41 (+3.24%)

, HPQ

HP Inc.

$17.13 /

+0.06 (+0.35%)

, TWTR

Twitter

$33.06 /

-0.96 (-2.82%)

, FB

Facebook

$229.17 /

-2.97 (-1.28%)

, IOVA

Iovance Biotherapeutics

$38.12 /

+0.66 (+1.76%)

Check out this morning's…

Open Full Text

ShowHide Related Items >><<
WDAY Workday
$170.10 /

+1.72 (+1.02%)

TWTR Twitter
$33.06 /

-0.96 (-2.82%)

TGI Triumph Group
$8.18 /

+1.92 (+30.67%)

LL Lumber Liquidators
$9.53 /

+0.79 (+9.04%)

IOVA Iovance Biotherapeutics
$38.12 /

+0.66 (+1.76%)

HPQ HP Inc.
$17.13 /

+0.06 (+0.35%)

FB Facebook
$229.17 /

-2.97 (-1.28%)

DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

DG Dollar General
$186.80 /

+6.41 (+3.55%)

CSIQ Canadian Solar
$19.29 /

+0.265 (+1.39%)

BURL Burlington Stores
$210.31 /

+1.44 (+0.69%)

BA Boeing
$149.46 /

+4.77 (+3.30%)

ANF Abercrombie & Fitch
$13.08 /

+0.41 (+3.24%)

AMGN Amgen
$224.81 /

+2.55 (+1.15%)

ALXN Alexion
$106.17 /

+3.4 (+3.31%)

ALXN Alexion
$106.17 /

+3.4 (+3.31%)

05/28/20 Piper Sandler
Alexion settlement could 'clear the deck' for acquirer, says Piper Sandler
05/28/20 Cowen
Alexion settlement may yield upside surprise, says Cowen
05/28/20 Stifel
Alexion, Amgen appear to have agreed to settlement deal, says Stifel
05/26/20 BMO Capital
BMO Capital still sees favorable risk/reward in Alexion following Argenx news
AMGN Amgen
$224.81 /

+2.55 (+1.15%)

05/22/20 Piper Sandler
Harpoon Therapeutics initiated with an Overweight at Piper Sandler
BA Boeing
$149.46 /

+4.77 (+3.30%)

05/28/20 BMO Capital
Hexcel price target raised to $45 from $37 at BMO Capital
05/22/20 Canaccord
Boeing price target lowered to $155 from $175 at Canaccord
05/20/20 RBC Capital
RBC starts Boeing at Outperform on favorable risk/reward profile
05/20/20 RBC Capital
Boeing initiated with an Outperform at RBC Capital
DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

05/26/20 Deutsche Bank
Dollar Tree price target raised to $97 from $87 at Deutsche Bank
05/18/20 Gordon Haskett
Colgate, Dollar Tree speculated as possible Peltz targets by Gordon Haskett
05/18/20
Fly Intel: Top five analyst initiations
05/18/20 Goldman Sachs
Dollar Tree initiated with a Buy at Goldman Sachs
LL Lumber Liquidators
$9.53 /

+0.79 (+9.04%)

01/21/20
Fly Intel: Top five analyst downgrades
01/21/20 Morgan Stanley
Lumber Liquidators downgraded to Underweight from Equal Weight at Morgan Stanley
12/04/19 Wedbush
Floor & Decor to see earnings boost from tariff exclusion, says Wedbush
09/13/19 Raymond James
Lumber Liquidators price target raised to $14 from $10 at Raymond James
TGI Triumph Group
$8.18 /

+1.92 (+30.67%)

03/20/20 BofA
BofA double downgrades Triumph, slashes price target amid COVID-19 impact
03/20/20 BofA
Triumph Group downgraded to Underperform from Buy at BofA
03/11/20 Goldman Sachs
Goldman cuts targets across Aerospace coverage for COVID-19 impact
08/23/19
Fly Intel: Top five analyst downgrades
CSIQ Canadian Solar
$19.29 /

+0.265 (+1.39%)

03/25/20 Roth Capital
ITC extension 'NOT' in Phase 3 coronavirus rescue package, says Roth Capital
10/07/19 Goldman Sachs
Goldman says U.S. solar makers should benefit from end of bifacial exemption
08/16/19 Roth Capital
Canadian Solar price target raised to $32 from $27 at Roth Capital
WDAY Workday
$170.10 /

+1.72 (+1.02%)

05/28/20 Needham
Workday price target raised to $200 from $175 at Needham
05/28/20 Wells Fargo
Workday price target raised to $195 from $155 at Wells Fargo
05/28/20 Wedbush
Workday price target lowered to $196 from $206 at Wedbush
05/28/20 Deutsche Bank
Workday price target raised to $180 from $150 at Deutsche Bank
DG Dollar General
$186.80 /

+6.41 (+3.55%)

05/26/20 Deutsche Bank
Dollar General price target raised to $187 from $159 at Deutsche Bank
05/18/20 Goldman Sachs
Dollar General initiated with a Buy at Goldman Sachs
04/30/20
Fly Intel: Top five analyst downgrades
BURL Burlington Stores
$210.31 /

+1.44 (+0.69%)

05/11/20 Nomura Instinet
Burlington Stores price target raised to $190 from $170 at Nomura Instinet
03/24/20 Citi
Burlington Stores price target lowered to $205 from $260 at Citi
03/19/20 Nomura Instinet
Burlington Stores price target lowered to $170 from $252 at Nomura Instinet
03/11/20
Fly Intel: Top five analyst upgrades
ANF Abercrombie & Fitch
$13.08 /

+0.41 (+3.24%)

04/03/20
Fly Intel: Top five analyst upgrades
04/03/20 B. Riley FBR
B. Riley FBR upgrades Abercrombie on ability to 'weather the storm'
04/03/20 B. Riley FBR
Abercrombie & Fitch upgraded to Buy from Neutral at B. Riley FBR
03/24/20 Wedbush
Microsoft, Alphabet among stocks in Wedbush's Shopping List
HPQ HP Inc.
$17.13 /

+0.06 (+0.35%)

05/28/20 JPMorgan
HP Inc. downgraded to Neutral from Overweight at JPMorgan
05/26/20 Credit Suisse
HP Inc. price target lowered to $17 from $22 at Credit Suisse
05/22/20 JPMorgan
HP shares worth owning through downturn, says JPMorgan
04/27/20 Loop Capital
Xerox, Park City, NetApp, HP Enterprise cut to Hold from Buy at Loop Capital
TWTR Twitter
$33.06 /

-0.96 (-2.82%)

05/27/20 Cowen
Cowen says Twitter 'will be fine,' but Republicans could support Facebook suit
05/06/20 China Renaissance
Twitter price target lowered to $23 from $25 at China Renaissance
05/01/20
Fly Intel: Top five analyst downgrades
05/01/20 Deutsche Bank
Twitter price target raised to $28 from $22 at Deutsche Bank
FB Facebook
$229.17 /

-2.97 (-1.28%)

05/27/20 Citi
Facebook price target raised to $275 from $245 at Citi
05/21/20 Stifel
Facebook price target raised to $260 from $245 at Stifel
05/20/20 Deutsche Bank
Facebook Shops could be $30B revenue opportunity, says Deutsche Bank
IOVA Iovance Biotherapeutics
$38.12 /

+0.66 (+1.76%)

05/28/20 Piper Sandler
Iovance melanoma data 'fully supportive of approval,' says Piper Sandler
04/29/20 Oppenheimer
Iovance Biotherapeutics price target raised to $43 from $35 at Oppenheimer
04/29/20 H.C. Wainwright
Iovance Biotherapeutics price target raised to $48 from $36 at H.C. Wainwright
04/27/20 Piper Sandler
AACR abstract for Moffitt study positive for Iovance, says Piper Sandler
WDAY Workday
$170.10 /

+1.72 (+1.02%)

TWTR Twitter
$33.06 /

-0.96 (-2.82%)

TGI Triumph Group
$8.18 /

+1.92 (+30.67%)

LL Lumber Liquidators
$9.53 /

+0.79 (+9.04%)

IOVA Iovance Biotherapeutics
$38.12 /

+0.66 (+1.76%)

HPQ HP Inc.
$17.13 /

+0.06 (+0.35%)

FB Facebook
$229.17 /

-2.97 (-1.28%)

DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

DG Dollar General
$186.80 /

+6.41 (+3.55%)

CSIQ Canadian Solar
$19.29 /

+0.265 (+1.39%)

BURL Burlington Stores
$210.31 /

+1.44 (+0.69%)

BA Boeing
$149.46 /

+4.77 (+3.30%)

ANF Abercrombie & Fitch
$13.08 /

+0.41 (+3.24%)

AMGN Amgen
$224.81 /

+2.55 (+1.15%)

ALXN Alexion
$106.17 /

+3.4 (+3.31%)

  • 29
    May
TWTR Twitter
$33.06 /

-0.96 (-2.82%)

IOVA Iovance Biotherapeutics
$38.12 /

+0.66 (+1.76%)

HPQ HP Inc.
$17.13 /

+0.06 (+0.35%)

FB Facebook
$229.17 /

-2.97 (-1.28%)

DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

CSIQ Canadian Solar
$19.29 /

+0.265 (+1.39%)

BA Boeing
$149.46 /

+4.77 (+3.30%)

ANF Abercrombie & Fitch
$13.08 /

+0.41 (+3.24%)

AMGN Amgen
$224.81 /

+2.55 (+1.15%)

ALXN Alexion
$106.17 /

+3.4 (+3.31%)

WDAY Workday
$170.10 /

+1.72 (+1.02%)

TWTR Twitter
$33.06 /

-0.96 (-2.82%)

LL Lumber Liquidators
$9.53 /

+0.79 (+9.04%)

IOVA Iovance Biotherapeutics
$38.12 /

+0.66 (+1.76%)

HPQ HP Inc.
$17.13 /

+0.06 (+0.35%)

FB Facebook
$229.17 /

-2.97 (-1.28%)

DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

DG Dollar General
$186.80 /

+6.41 (+3.55%)

CSIQ Canadian Solar
$19.29 /

+0.265 (+1.39%)

BURL Burlington Stores
$210.31 /

+1.44 (+0.69%)

BA Boeing
$149.46 /

+4.77 (+3.30%)

ANF Abercrombie & Fitch
$13.08 /

+0.41 (+3.24%)

AMGN Amgen
$224.81 /

+2.55 (+1.15%)

ALXN Alexion
$106.17 /

+3.4 (+3.31%)

WDAY Workday
$170.10 /

+1.72 (+1.02%)

TWTR Twitter
$33.06 /

-0.96 (-2.82%)

LL Lumber Liquidators
$9.53 /

+0.79 (+9.04%)

IOVA Iovance Biotherapeutics
$38.12 /

+0.66 (+1.76%)

HPQ HP Inc.
$17.13 /

+0.06 (+0.35%)

FB Facebook
$229.17 /

-2.97 (-1.28%)

DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

DG Dollar General
$186.80 /

+6.41 (+3.55%)

CSIQ Canadian Solar
$19.29 /

+0.265 (+1.39%)

BURL Burlington Stores
$210.31 /

+1.44 (+0.69%)

BA Boeing
$149.46 /

+4.77 (+3.30%)

ANF Abercrombie & Fitch
$13.08 /

+0.41 (+3.24%)

ALXN Alexion
$106.17 /

+3.4 (+3.31%)

Recommendations
Iovance melanoma data 'fully supportive of approval,' says Piper Sandler » 04:57
05/28/20
05/28
04:57
05/28/20
04:57
IOVA

Iovance Biotherapeutics

$38.12 /

+0.66 (+1.76%)

Iovance…

Iovance Biotherapeutics' interim results from lifileucel's pivotal melanoma cohort 4 last night had an overall response rate of 32.4%, inclusive of two unconfirmed responses, which is consistent with prior data for lifileucel in melanoma, namely cohort 2, Piper Sandler analyst Joseph Catanzaro tells investors in a research note. The analyst believes the data package are "fully supportive of approval" in post-PD-1 melanoma. Lifileucel's clinical profile in melanoma continues to mature "very favorably" and it remains well-positioned for a potential commercial launch in 2021, says Catanzaro, who keeps an Overweight rating on Iovance with a $40 price target.

ShowHide Related Items >><<
IOVA Iovance Biotherapeutics
$38.12 /

+0.66 (+1.76%)

IOVA Iovance Biotherapeutics
$38.12 /

+0.66 (+1.76%)

04/29/20 Oppenheimer
Iovance Biotherapeutics price target raised to $43 from $35 at Oppenheimer
04/29/20 H.C. Wainwright
Iovance Biotherapeutics price target raised to $48 from $36 at H.C. Wainwright
04/27/20 Piper Sandler
AACR abstract for Moffitt study positive for Iovance, says Piper Sandler
04/22/20 Piper Sandler
AACR meeting should bring more support for Iovance TILs, says Piper Sandler
IOVA Iovance Biotherapeutics
$38.12 /

+0.66 (+1.76%)

  • 29
    May
IOVA Iovance Biotherapeutics
$38.12 /

+0.66 (+1.76%)

IOVA Iovance Biotherapeutics
$38.12 /

+0.66 (+1.76%)

IOVA Iovance Biotherapeutics
$38.12 /

+0.66 (+1.76%)

On The Fly
Fly Intel: After-Hours Movers » 19:08
05/27/20
05/27
19:08
05/27/20
19:08
NTNX

Nutanix

$24.94 /

+0.53 (+2.17%)

, COHR

Coherent

$149.11 /

+3.8 (+2.62%)

, HPQ

HP Inc.

$17.13 /

+0.06 (+0.35%)

, NTAP

NetApp

$46.30 /

+1.23 (+2.73%)

, ADSK

Autodesk

$199.71 /

+0.28 (+0.14%)

, HTZ

Hertz

$1.31 /

+0.7199 (+122.00%)

, IOVA

Iovance Biotherapeutics

$38.12 /

+0.66 (+1.76%)

, ARNA

Arena Pharmaceuticals

$58.07 /

+1.16 (+2.04%)

, CRNC

Cerence

$33.05 /

+0.47 (+1.44%)

, BCRX

BioCryst

$5.03 /

-0.17 (-3.27%)

, IMMU

Immunomedics

$34.18 /

+0.1 (+0.29%)

, PEN

Penumbra

$170.74 /

+1.29 (+0.76%)

, TWTR

Twitter

$33.06 /

-0.96 (-2.82%)

, PLT

Plantronics

$14.66 /

+0.67 (+4.79%)

, IMAB

I-MAB

$23.87 /

+0.665 (+2.87%)

, BA

Boeing

$149.46 /

+4.77 (+3.30%)

, HPP

Hudson Pacific

$24.18 /

+1.06 (+4.59%)

, DHC

Diversified Healthcare Trust

$3.23 /

+0.03 (+0.94%)

, PLMR

Palomar

$65.68 /

+2.57 (+4.07%)

, PHAS

PhaseBio

$4.42 /

-0.03 (-0.67%)

, SPTN

SpartanNash

$20.57 /

-0.02 (-0.10%)

, WDAY

Workday

$170.10 /

+1.72 (+1.02%)

, TOL

Toll Brothers

$32.95 /

+2.835 (+9.42%)

, BGFV

Big 5 Sporting

$1.94 /

+0.06 (+3.19%)

, SMTC

Semtech

$50.13 /

+1.18 (+2.41%)

Check out this evening's…

Open Full Text

ShowHide Related Items >><<
WDAY Workday
$170.10 /

+1.72 (+1.02%)

TWTR Twitter
$33.06 /

-0.96 (-2.82%)

TOL Toll Brothers
$32.95 /

+2.835 (+9.42%)

SPTN SpartanNash
$20.57 /

-0.02 (-0.10%)

SMTC Semtech
$50.13 /

+1.18 (+2.41%)

PLT Plantronics
$14.66 /

+0.67 (+4.79%)

PLMR Palomar
$65.68 /

+2.57 (+4.07%)

PHAS PhaseBio
$4.42 /

-0.03 (-0.67%)

PEN Penumbra
$170.74 /

+1.29 (+0.76%)

NTNX Nutanix
$24.94 /

+0.53 (+2.17%)

NTAP NetApp
$46.30 /

+1.23 (+2.73%)

IOVA Iovance Biotherapeutics
$38.12 /

+0.66 (+1.76%)

IMMU Immunomedics
$34.18 /

+0.1 (+0.29%)

IMAB I-MAB
$23.87 /

+0.665 (+2.87%)

HTZ Hertz
$1.31 /

+0.7199 (+122.00%)

HPQ HP Inc.
$17.13 /

+0.06 (+0.35%)

HPP Hudson Pacific
$24.18 /

+1.06 (+4.59%)

DHC Diversified Healthcare Trust
$3.23 /

+0.03 (+0.94%)

CRNC Cerence
$33.05 /

+0.47 (+1.44%)

COHR Coherent
$149.11 /

+3.8 (+2.62%)

BGFV Big 5 Sporting
$1.94 /

+0.06 (+3.19%)

BCRX BioCryst
$5.03 /

-0.17 (-3.27%)

BA Boeing
$149.46 /

+4.77 (+3.30%)

ARNA Arena Pharmaceuticals
$58.07 /

+1.16 (+2.04%)

ADSK Autodesk
$199.71 /

+0.28 (+0.14%)

NTNX Nutanix
$24.94 /

+0.53 (+2.17%)

05/21/20 JPMorgan
Nutanix price target lowered to $24 from $27 at JPMorgan
05/19/20 OTR Global
Nutanix downgraded to Mixed from Positive at OTR Global
04/27/20 Needham
Nutanix price target lowered to $24 from $42 at Needham
04/23/20 Cleveland Research
Nutanix trends in April softened versus prior months, says Cleveland Research
COHR Coherent
$149.11 /

+3.8 (+2.62%)

04/23/20 Goldman Sachs
Coherent upgraded to Buy from Neutral at Goldman Sachs
02/10/20
Fly Intel: Top five analyst initiations
02/10/20 Stifel
Coherent transferred with a Buy, $178 price target at Stifel
02/06/20 Piper Sandler
Coherent price target lowered to $195 from $205 at Piper Sandler
HPQ HP Inc.
$17.13 /

+0.06 (+0.35%)

05/26/20 Credit Suisse
HP Inc. price target lowered to $17 from $22 at Credit Suisse
05/22/20 JPMorgan
HP shares worth owning through downturn, says JPMorgan
04/27/20 Loop Capital
Xerox, Park City, NetApp, HP Enterprise cut to Hold from Buy at Loop Capital
04/21/20 Deutsche Bank
HP Inc. price target lowered to $17 from $20 at Deutsche Bank
NTAP NetApp
$46.30 /

+1.23 (+2.73%)

05/19/20 Barclays
Barclays lowers estimates in IT hardware after April survey
05/11/20
Fly Intel: Top five analyst downgrades
05/11/20 Stifel
NetApp downgraded to Hold from Buy at Stifel
ADSK Autodesk
$199.71 /

+0.28 (+0.14%)

05/22/20 Deutsche Bank
Autodesk price target lowered to $215 from $230 at Deutsche Bank
05/21/20 Citi
Citi sees difficult setup for Autodesk into results, cuts price target
05/19/20 KeyBanc
Autodesk price target raised to $210 from $200 at KeyBanc
05/07/20 OTR Global
Autodesk downgraded to Mixed from Positive at OTR Global
HTZ Hertz
$1.31 /

+0.7199 (+122.00%)

05/05/20 Morgan Stanley
2020 may not be quite as bad as feared for used cars, says Morgan Stanley
04/27/20
Fly Intel: Top five analyst downgrades
04/27/20 Barclays
Barclays downgrades Hertz to Underweight on risk of capital call
04/27/20 Barclays
Hertz downgraded to Underweight from Equal Weight at Barclays
IOVA Iovance Biotherapeutics
$38.12 /

+0.66 (+1.76%)

04/29/20 Oppenheimer
Iovance Biotherapeutics price target raised to $43 from $35 at Oppenheimer
04/29/20 H.C. Wainwright
Iovance Biotherapeutics price target raised to $48 from $36 at H.C. Wainwright
04/27/20 Piper Sandler
AACR abstract for Moffitt study positive for Iovance, says Piper Sandler
04/22/20 Piper Sandler
AACR meeting should bring more support for Iovance TILs, says Piper Sandler
ARNA Arena Pharmaceuticals
$58.07 /

+1.16 (+2.04%)

05/18/20
Fly Intel: Top five analyst initiations
05/18/20 Jefferies
Arena Pharmaceuticals initiated with a Buy at Jefferies
05/18/20 Jefferies
Arena Pharmaceuticals initiated with a Buy at Jefferies
03/31/20 Guggenheim
Guggenheim starts Arena at Buy on 'pipeline-in-a-product' etrasimod
CRNC Cerence
$33.05 /

+0.47 (+1.44%)

05/27/20 Wedbush
Cerence price target raised to $40 from $27 at Wedbush
05/26/20 Raymond James
Cerence downgraded to Outperform from Strong Buy at Raymond James
05/26/20 Raymond James
Cerence downgraded to Outperform from Strong Buy at Raymond James
05/12/20
Fly Intel: Top five analyst initiations
BCRX BioCryst
$5.03 /

-0.17 (-3.27%)

05/06/20 JMP Securities
BioCryst has potential best-in-class PNH treatment, says JMP Securities
05/06/20 Piper Sandler
BioCryst price target raised to $10 from $8 at Piper Sandler
05/05/20 Barclays
BioCryst upgraded to Overweight from Equal Weight at Barclays
04/29/20 JMP Securities
Positive remdesivir news 'bodes well' for BioCryst, says JMP Securities
IMMU Immunomedics
$34.18 /

+0.1 (+0.29%)

05/06/20 Piper Sandler
Immunomedics well positioned to execute on Trodelvy launch, says Piper Sandler
05/05/20 Barclays
Immunomedics initiated with an Overweight, $40 target at Barclays
05/04/20 Barclays
Immunomedics initiated with an Overweight at Barclays
04/24/20
Fly Intel: Top five analyst upgrades
PEN Penumbra
$170.74 /

+1.29 (+0.76%)

05/08/20 Citi
Penumbra price target raised to $214 from $192 at Citi
03/04/20 Citi
Penumbra initiated with a Buy at Citi
03/02/20 Wells Fargo
Baxter, J&J best positioned to weather coronavirus spread, says Wells Fargo
02/26/20 Canaccord
Penumbra weakness buying opportunity, says Canaccord
TWTR Twitter
$33.06 /

-0.96 (-2.82%)

05/27/20 Cowen
Cowen says Twitter 'will be fine,' but Republicans could support Facebook suit
05/06/20 China Renaissance
Twitter price target lowered to $23 from $25 at China Renaissance
05/01/20
Fly Intel: Top five analyst downgrades
05/01/20 Deutsche Bank
Twitter price target raised to $28 from $22 at Deutsche Bank
PLT Plantronics
$14.66 /

+0.67 (+4.79%)

04/16/20 Morgan Stanley
Morgan Stanley cuts Plantronics to Underweight citing upcoming challenges
04/16/20 Morgan Stanley
Plantronics downgraded to Underweight from Equal Weight at Morgan Stanley
03/30/20 JPMorgan
Plantronics downgraded to Underweight from Neutral at JPMorgan
03/30/20 JPMorgan
Plantronics downgraded to Underweight from Neutral at JPMorgan
IMAB I-MAB
$23.87 /

+0.665 (+2.87%)

02/14/20
Fly Intel: Top five analyst initiations
02/13/20 CICC
I-MAB initiated with an Outperform at CICC
02/12/20
Fly Intel: Top five analyst initiations
02/11/20 China Renaissance
I-MAB initiated with a Buy at China Renaissance
BA Boeing
$149.46 /

+4.77 (+3.30%)

05/22/20 Canaccord
Boeing price target lowered to $155 from $175 at Canaccord
05/20/20 RBC Capital
RBC starts Boeing at Outperform on favorable risk/reward profile
05/20/20 RBC Capital
Boeing initiated with an Outperform at RBC Capital
05/05/20 Nord/LB
Boeing downgraded to Sell from Hold at Nord/LB
HPP Hudson Pacific
$24.18 /

+1.06 (+4.59%)

04/16/20 Jefferies
Hudson Pacific initiated with a Hold at Jefferies
02/04/20 Mizuho
Hudson Pacific assumed with a Buy at Mizuho
01/15/20 Mizuho
Hudson Pacific upgraded to Buy from Neutral at Mizuho
11/08/19 Goldman Sachs
Hudson Pacific initiated with a Buy at Goldman Sachs
DHC Diversified Healthcare Trust
$3.23 /

+0.03 (+0.94%)

05/19/20 RBC Capital
Diversified Healthcare Trust price target lowered to $3 from $7 at RBC Capital
03/11/20 Mizuho
Sabra Health Care to be pressured by coronavirus at facility, says Mizuho
01/16/20 Wells Fargo
Diversified Healthcare Trust cut to Equal Weight from Overweight at Wells Fargo
01/07/20 Raymond James
Healthcare REIT sector downgraded to Market Weight at Raymond James
PLMR Palomar
$65.68 /

+2.57 (+4.07%)

01/14/20 JMP Securities
Palomar price target raised to $55 from $50 at JMP Securities
01/10/20 Keefe Bruyette
Palomar target raised to $58 after share offering at Keefe Bruyette
12/16/19 William Blair
Palomar should be bought despite recent rally, says William Blair
12/08/19 Keefe Bruyette
Palomar price target raised to $57 from $48 at Keefe Bruyette
PHAS PhaseBio
$4.42 /

-0.03 (-0.67%)

05/07/20 Stifel
Portola deal highlights value of PhaseBio's PB2452, says Stifel
04/06/20 Citi
PhaseBio price target lowered to $11 from $25 at Citi
01/27/20 William Blair
PhaseBio could see increase to PB2452 addressable market, says William Blair
01/16/20 Stifel
PhaseBio acquisition of PB6440 an 'excellent' strategic move, says Stifel
SPTN SpartanNash
$20.57 /

-0.02 (-0.10%)

03/19/20 Barclays
SpartanNash upgraded to Equal Weight from Underweight at Barclays
03/18/20 BMO Capital
SpartanNash upgraded to Market Perform from Underperform at BMO Capital
10/04/19
SpartanNash management to meet with Loop Capital
WDAY Workday
$170.10 /

+1.72 (+1.02%)

05/21/20 OTR Global
Workday downgraded to Mixed from Positive at OTR Global
05/18/20
Fly Intel: Top five analyst downgrades
05/18/20 Cleveland Research
Workday downgraded to Neutral from Buy at Cleveland Research
05/18/20 RBC Capital
Workday price target lowered to $194 from $230 at RBC Capital
TOL Toll Brothers
$32.95 /

+2.835 (+9.42%)

05/27/20 Credit Suisse
Toll Brothers initiated with a Neutral at Credit Suisse
05/27/20 Credit Suisse
KB Home initiated with an Outperform at Credit Suisse
05/11/20 Wedbush
Toll Brothers price target lowered to $35 from $48 at Wedbush
05/04/20 Evercore ISI
Toll Brothers upgraded to In Line from Underperform at Evercore ISI
BGFV Big 5 Sporting
$1.94 /

+0.06 (+3.19%)

SMTC Semtech
$50.13 /

+1.18 (+2.41%)

03/12/20 Susquehanna
Semtech results inline and guidance better than feared, says Susquehanna
03/12/20 Loop Capital
Semtech price target lowered to $46 from $56 at Loop Capital
03/12/20 B. Riley FBR
Semtech price target lowered to $50 from $55 at B. Riley FBR
03/12/20 Needham
Semtech upgraded to Buy from Hold at Needham
WDAY Workday
$170.10 /

+1.72 (+1.02%)

TWTR Twitter
$33.06 /

-0.96 (-2.82%)

TOL Toll Brothers
$32.95 /

+2.835 (+9.42%)

SPTN SpartanNash
$20.57 /

-0.02 (-0.10%)

SMTC Semtech
$50.13 /

+1.18 (+2.41%)

PLT Plantronics
$14.66 /

+0.67 (+4.79%)

PLMR Palomar
$65.68 /

+2.57 (+4.07%)

PHAS PhaseBio
$4.42 /

-0.03 (-0.67%)

PEN Penumbra
$170.74 /

+1.29 (+0.76%)

NTNX Nutanix
$24.94 /

+0.53 (+2.17%)

NTAP NetApp
$46.30 /

+1.23 (+2.73%)

IOVA Iovance Biotherapeutics
$38.12 /

+0.66 (+1.76%)

IMMU Immunomedics
$34.18 /

+0.1 (+0.29%)

IMAB I-MAB
$23.87 /

+0.665 (+2.87%)

HTZ Hertz
$1.31 /

+0.7199 (+122.00%)

HPQ HP Inc.
$17.13 /

+0.06 (+0.35%)

HPP Hudson Pacific
$24.18 /

+1.06 (+4.59%)

DHC Diversified Healthcare Trust
$3.23 /

+0.03 (+0.94%)

CRNC Cerence
$33.05 /

+0.47 (+1.44%)

COHR Coherent
$149.11 /

+3.8 (+2.62%)

BGFV Big 5 Sporting
$1.94 /

+0.06 (+3.19%)

BCRX BioCryst
$5.03 /

-0.17 (-3.27%)

BA Boeing
$149.46 /

+4.77 (+3.30%)

ARNA Arena Pharmaceuticals
$58.07 /

+1.16 (+2.04%)

ADSK Autodesk
$199.71 /

+0.28 (+0.14%)

  • 29
    May
  • 28
    May
  • 28
    May
  • 28
    May
TWTR Twitter
$33.06 /

-0.96 (-2.82%)

PLT Plantronics
$14.66 /

+0.67 (+4.79%)

NTNX Nutanix
$24.94 /

+0.53 (+2.17%)

IOVA Iovance Biotherapeutics
$38.12 /

+0.66 (+1.76%)

IMMU Immunomedics
$34.18 /

+0.1 (+0.29%)

HTZ Hertz
$1.31 /

+0.7199 (+122.00%)

HPQ HP Inc.
$17.13 /

+0.06 (+0.35%)

HPP Hudson Pacific
$24.18 /

+1.06 (+4.59%)

BA Boeing
$149.46 /

+4.77 (+3.30%)

ADSK Autodesk
$199.71 /

+0.28 (+0.14%)

WDAY Workday
$170.10 /

+1.72 (+1.02%)

TWTR Twitter
$33.06 /

-0.96 (-2.82%)

TOL Toll Brothers
$32.95 /

+2.835 (+9.42%)

PLT Plantronics
$14.66 /

+0.67 (+4.79%)

PLMR Palomar
$65.68 /

+2.57 (+4.07%)

PEN Penumbra
$170.74 /

+1.29 (+0.76%)

NTNX Nutanix
$24.94 /

+0.53 (+2.17%)

NTAP NetApp
$46.30 /

+1.23 (+2.73%)

IOVA Iovance Biotherapeutics
$38.12 /

+0.66 (+1.76%)

IMMU Immunomedics
$34.18 /

+0.1 (+0.29%)

IMAB I-MAB
$23.87 /

+0.665 (+2.87%)

HTZ Hertz
$1.31 /

+0.7199 (+122.00%)

HPQ HP Inc.
$17.13 /

+0.06 (+0.35%)

CRNC Cerence
$33.05 /

+0.47 (+1.44%)

BCRX BioCryst
$5.03 /

-0.17 (-3.27%)

BA Boeing
$149.46 /

+4.77 (+3.30%)

ARNA Arena Pharmaceuticals
$58.07 /

+1.16 (+2.04%)

ADSK Autodesk
$199.71 /

+0.28 (+0.14%)

WDAY Workday
$170.10 /

+1.72 (+1.02%)

TWTR Twitter
$33.06 /

-0.96 (-2.82%)

TOL Toll Brothers
$32.95 /

+2.835 (+9.42%)

PLT Plantronics
$14.66 /

+0.67 (+4.79%)

PHAS PhaseBio
$4.42 /

-0.03 (-0.67%)

NTNX Nutanix
$24.94 /

+0.53 (+2.17%)

NTAP NetApp
$46.30 /

+1.23 (+2.73%)

IOVA Iovance Biotherapeutics
$38.12 /

+0.66 (+1.76%)

IMMU Immunomedics
$34.18 /

+0.1 (+0.29%)

HTZ Hertz
$1.31 /

+0.7199 (+122.00%)

HPQ HP Inc.
$17.13 /

+0.06 (+0.35%)

DHC Diversified Healthcare Trust
$3.23 /

+0.03 (+0.94%)

BCRX BioCryst
$5.03 /

-0.17 (-3.27%)

BA Boeing
$149.46 /

+4.77 (+3.30%)

ADSK Autodesk
$199.71 /

+0.28 (+0.14%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.